Between Moral Hazard and Legal Uncertainty: Ethical, Legal and Societal Challenges of Human Genome Editing
Genome Editing Techniques are seen to be at the frontier of current research in the field of emerging biotechnologies. The latest revolutionary development, the so-called CRISPR technology, represents a paradigmatic example of the ambiguity of such techniques and has resulted in an international int...
| Contributors: | ; ; |
|---|---|
| Format: | Electronic Book |
| Language: | English |
| Check availability: | HBZ Gateway |
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiesbaden
Springer Fachmedien Wiesbaden
2018
|
| In: | Year: 2018 |
| Series/Journal: | Technikzukünfte, Wissenschaft und Gesellschaft / Futures of Technology, Science and Society
SpringerLink Bücher |
| Standardized Subjects / Keyword chains: | B
Genome editing
/ CRISP/Cas method
/ Bioethics
|
| Further subjects: | B
Research—Moral and ethical aspects
B philosophy of technology B Bioethics B Research-Moral and ethical aspec B Philosophy |
| Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) |
| Parallel Edition: | Non-electronic
Printed edition: 9783658226596 Printed edition: 9783658226619 |
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | 1041329393 | ||
| 003 | DE-627 | ||
| 005 | 20230427222846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181203s2018 gw |||||o 00| ||eng c | ||
| 020 | |a 9783658226602 |9 978-3-658-22660-2 | ||
| 024 | 7 | |a 10.1007/978-3-658-22660-2 |2 doi | |
| 035 | |a (DE-627)1041329393 | ||
| 035 | |a (DE-576)514720751 | ||
| 035 | |a (DE-599)GBV1041329393 | ||
| 035 | |a (DE-He213)978-3-658-22660-2 | ||
| 035 | |a (EBP)066050812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE | ||
| 050 | 0 | |a B53 | |
| 082 | 0 | |a 601 | |
| 084 | |a 1 |2 ssgn | ||
| 084 | |a CC 7264 |q SEPA |2 rvk |0 (DE-625)rvk/17679: | ||
| 084 | |a PJ 2280 |q SEPA |2 rvk |0 (DE-625)rvk/136655: | ||
| 084 | |a QD |2 thema | ||
| 084 | |a HP |2 bicssc | ||
| 084 | |a PHI021000 |2 bisacsh | ||
| 084 | |a 86.56 |2 bkl | ||
| 245 | 1 | 0 | |a Between Moral Hazard and Legal Uncertainty |b Ethical, Legal and Societal Challenges of Human Genome Editing |c edited by Matthias Braun, Hannah Schickl, Peter Dabrock |
| 264 | 1 | |a Wiesbaden |b Springer Fachmedien Wiesbaden |c 2018 | |
| 300 | |a Online-Ressource (IX, 225 p. 1 illus, online resource) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Technikzukünfte, Wissenschaft und Gesellschaft / Futures of Technology, Science and Society | |
| 490 | 0 | |a SpringerLink |a Bücher | |
| 520 | |a Genome Editing Techniques are seen to be at the frontier of current research in the field of emerging biotechnologies. The latest revolutionary development, the so-called CRISPR technology, represents a paradigmatic example of the ambiguity of such techniques and has resulted in an international interdisciplinary debate on whether or not it is necessary to ban the application of this technique by means of a moratorium on its use for human germline modifications, particularly in human embryos in the reproduction process. However, given that other germline engineering techniques like mitochondrial (mt) DNA transfer techniques are already permitted and applied, the question arises what lies at the root of the apparent social unease about the modification of the human germline by Genome Editing Techniques like CRISPR. Against this background, the book seeks to make a substantial contribution to the current debate about a responsible and participatory framework for research on emerging biotechnologies by analysing underlying perceptions, attitudes, arguments and the reasoning on Genome Editing Techniques. Contents Mapping the current legal framing Theoretical Challenges Orientation markers for a Governance Frame in dealing with Genome Editing Target Groups Scientist, Policy Makers, Lecturers and students in the fields of Ethics, Philosophy, Theology, Law, Social and Political Science. The Editors Matthias Braun is assistant Professor at the Chair of Systematic Theology II (Ethics), Friedrich-Alexander University Erlangen-Nuremberg. Hannah Schickl is research assistant in the Interdisciplinary Research Group “Gene Technology Report”, Berlin-Brandenburg Academy of Sciences and Humanities. Peter Dabrock is Professor of Systematic Theology/Ethics at the Friedrich-Alexander University Erlangen-Nuremberg and Chair of the German Ethics Council | ||
| 520 | |a Mapping the Current Legal Framing -- Theoretical Challenges -- Orientation Markers for a Governance Frame in Dealing with Genome Editing | ||
| 533 | |f Springer eBook Collection. Religion and Philosophy | ||
| 601 | |a Challenger | ||
| 650 | 0 | |a Research-Moral and ethical aspec | |
| 650 | 0 | |a philosophy of technology | |
| 650 | 0 | |a Philosophy | |
| 650 | 0 | |a Research-Moral and ethical aspec | |
| 650 | 0 | |a Bioethics | |
| 650 | 0 | |a Philosophy | |
| 650 | 0 | |a Bioethics | |
| 650 | 0 | |a Research—Moral and ethical aspects | |
| 689 | 0 | 0 | |d s |0 (DE-588)1116095971 |0 (DE-627)870158090 |0 (DE-576)478149689 |2 gnd |a Genome Editing |
| 689 | 0 | 1 | |d s |0 (DE-588)1116100770 |0 (DE-627)870163922 |0 (DE-576)478151292 |2 gnd |a CRISPR/Cas-Methode |
| 689 | 0 | 2 | |d s |0 (DE-588)4006791-9 |0 (DE-627)104585234 |0 (DE-576)208867074 |2 gnd |a Bioethik |
| 689 | 0 | |5 DE-101 | |
| 700 | 1 | |a Braun, Matthias |e HerausgeberIn |4 edt | |
| 700 | 1 | |e HerausgeberIn |0 (DE-588)1154329208 |0 (DE-627)1015594131 |0 (DE-576)50069124X |4 edt |a Schickl, Hannah | |
| 700 | 1 | |e HerausgeberIn |0 (DE-588)114170169 |0 (DE-627)501838112 |0 (DE-576)175302707 |4 edt |a Dabrock, Peter |d 1964- | |
| 776 | 1 | |z 9783658226596 | |
| 776 | 1 | |z 9783658226619 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Between moral hazard and legal uncertainty |d Wiesbaden : Springer Fachmedien Wiesbaden GmbH, 2018 |h IX, 225 Seiten |w (DE-627)1024121666 |w (DE-576)513932402 |z 9783658226596 |z 3658226595 |k Non-Electronic |
| 776 | 0 | 8 | |i Printed edition |z 9783658226596 |
| 776 | 0 | 8 | |i Printed edition |z 9783658226619 |
| 856 | |u https://link.springer.com/content/pdf/bfm:978-3-658-22660-2/1?pdf=chapter%20toc |x unpaywall |z Vermutlich kostenfreier Zugang |h repository [oa repository (via OAI-PMH doi match)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-658-22660-2 |m X:SPRINGER |x Verlag |z lizenzpflichtig |3 Volltext |
| 912 | |a ZDB-2-REP |b 2018 | ||
| 912 | |a ZDB-2-SEB | ||
| 912 | |a ZDB-2-SXPR |b 2018 | ||
| 935 | |i Blocktest | ||
| 936 | r | v | |a CC 7264 |b Bio- und Medizinethik |k Systematische Philosophie |k Ethik |k Angewandte Ethik (Bioethik, Medizinische Ethik, Ethik der einzelnen Wissenschaften) |k Bio- und Medizinethik |0 (DE-627)1320147151 |0 (DE-625)rvk/17679: |0 (DE-576)250147157 |
| 936 | r | v | |a PJ 2280 |b Forschung am Menschen (u.a. Reproduktionsmedizin, Genforschung und -technologie den Menschen betreffend) |k Medizinrecht (Biorecht, Recht des Gesundheitswesens, Arzneimittel- und Medizinproduktrecht, Medizinstrafrecht, Apothekenrecht) |k Ethisch-rechtliche Fragen zum Medizin- und Biorecht |k Forschung am Menschen (u.a. Reproduktionsmedizin, Genforschung und -technologie den Menschen betreffend) |0 (DE-627)1448227755 |0 (DE-625)rvk/136655: |0 (DE-576)378227750 |
| 936 | b | k | |a 86.56 |j Gesundheitsrecht |j Lebensmittelrecht |q SEPA |0 (DE-627)106416995 |
| 951 | |a BO | ||
| ELC | |a 1 | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheo_oa001.raw | ||
| REL | |a 1 | ||
| STA | 0 | 0 | |a Bioethics,CRISP/Cas method,CRISP/Cas9 method,CRISP/Cas9 method,Genome editing |
| STB | 0 | 0 | |a Bioéthique,Méthode CRISPR/Cas,Édition génomique |
| STC | 0 | 0 | |a Bioética,Edición de genoma,Método CRISPR/Cas |
| STD | 0 | 0 | |a Bioetica,Genome editing,Correzione del DNA,Correzione del DNA,Metodo CRISP/Cas,Metodo CRISP/Cas9,Metodo CRISP/Cas9 |
| STE | 0 | 0 | |a 生物伦理学,生物学伦理,生命伦理学 |
| STF | 0 | 0 | |a 基因组编辑,生物倫理學,生物學倫理,生命倫理學 |
| STG | 0 | 0 | |a Bioética,Edição de genoma,Método CRISPR/Cas |
| STH | 0 | 0 | |a Биоэтика,Метод CRISP/Cas,Редактирование генома |
| STI | 0 | 0 | |a Βιοηθική,Μέθοδος CRISPR/Cas,Μέθοδος CRISPR/Cas9,Τροποποίηση γονιδιώματος |
| SUB | |a REL | ||
| SYG | 0 | 0 | |a CRISPR/Cas9-Methode |